| Execution period | Within one month |
|---|---|
| plant size | 5000.0 Sq. meters |
BSE filing, NSE: KRONOX. Summary written from the filing by ALFA Finder's alert engine.
Kronox Lab Sciences Ltd: key numbers
- Share price
- ₹196.48
- Market cap
- ₹729.0 Cr
- Revenue (annual)
- ₹101.2 Cr
- Net profit (annual)
- ₹27.66 Cr
- P/E (TTM)
- 25.5×Sector 34.5×
- Promoter holding
- 64.26%-9.95% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kronox Lab Sciences Ltd
All →Kronox Lab Sciences Change in Control
Kronox Lab Sciences' share purchase agreement with Indo Borax was amended on October 22, 2026. The amendment deletes the seller lock-in and right of first refusal clauses.
Kronox Lab Sciences Other Announcement
Kronox Lab Sciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Kronox Lab Sciences Promoter Selling (Off-Market): ₹246.1 Cr
Three promoters (Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani) sold equity shares totaling Rs. 246.12 Crore through off-market transactions.
- Value
- ₹246.1 Cr
Kronox Lab Sciences Promoter Selling (Off-Market): ₹88.42 Cr
Promoter Jogindersingh Jaswal sold 9,796,400 equity shares of Kronox Lab Sciences, representing a 23.09% stake, for ₹88.42 Crore via an off-market transaction.
- Value
- ₹88.42 Cr
Kronox Lab Sciences Other Announcement
Kronox Lab Sciences has entered into a consultancy agreement with outgoing promoter Pritesh Ramani for support in R&D, production, and special projects.
Kronox Lab Sciences Business Update
Kronox Lab Sciences has entered into a consultancy agreement with outgoing promoter Jogindersingh Jaswal to provide transition support services in research, development, and production.
Other acquisition announcements
All →Emkay Global Financial Services Acquisition Worth ₹21.38 Cr
Emkay Capital, a subsidiary, will acquire Emkay Investment Managers for Rs.21.38 Crore cash. The related-party deal is at arm's length and payable in tranches.
- Value
- ₹21.38 Cr
- Execution
- 90 days
TVS Motor Company Acquisition Worth ₹25,000 Cr
TVS Motor will acquire 100% of Harita ARC Limited, a related-party shell, for a stated Rs 25,000 Crore. It supports the proposed consumer finance demerger.
- Value
- ₹25,000 Cr
Rite Zone Chemcon India Acquisition Worth ₹4.97 Cr
Rite Zone Chemcon's board approved acquiring 51% of Cleanux Green Solution via share swap for about INR 4.97 Crore. The board also approved preferential issues and an EGM on 23 November 2026.
- Value
- ₹4.97 Cr
eClerx Services Acquisition Worth ₹15.57 Cr
eClerx's board approved buying about 2% of Personiv Eclipse Inc. from its wholly owned subsidiary eClerx LLC for USD 1.64 million. The intra-group transfer adds no change to aggregate ownership.
- Value
- ₹15.57 Cr
- Execution
- 1 Month
Fortis Healthcare Acquisition Worth ₹277 Cr
Fortis Healthcare's wholly-owned subsidiary IHL acquired Suguna Hospital's business and land in Bengaluru via slump sale. The cumulative consideration is approximately INR 277 Crore, consummated today.
- Value
- ₹277.0 Cr
Authum Investment & Infrastructure Acquisition
NCLT approved the consortium resolution plan for A A Estates Private Limited, with Authum as a resolution applicant. No consideration amount is disclosed.